Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jacobs

Showing results (681-690 of 791) with videos related to

Pageof 80
Sort By:
Annals of the Rheumatic Diseases|March 17, 2011
Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA studyM F Bakker, J W G Jacobs, P M J Welsing, et al.
Arthritis Research & Therapy|September 10, 2020
The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trialM S Jurgens, M Safy-Khan, M J H de Hair, et al.
Arthritis Care & Research|March 26, 2021
Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) ScoresMaxime M A Verhoeven, Antonius A A Westgeest, Andreas Schwarting, et al.
Arthritis Research & Therapy|October 17, 2018
Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biologyXavier M Teitsma, Wei Yang, Johannes W G Jacobs, et al.
Annals of the Rheumatic Diseases|June 1, 2010
Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA studyM F Bakker, J W G Jacobs, P M J Welsing, et al.
Arthritis and Rheumatism|October 29, 2005
Is radiation synovectomy for arthritis of the knee more effective than intraarticular treatment with glucocorticoids? Results of an eighteen-month, randomized, double-blind, placebo-controlled, crossover trialZalima N Jahangier, Johannes W G Jacobs, Floris P J G Lafeber, et al.
The Journal of Rheumatology|August 3, 2020
Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid ArthritisMaxime M A Verhoeven, Janneke Tekstra, Jacob M van Laar, et al.
Prion|December 20, 2014
Sheep prions with molecular properties intermediate between classical scrapie, BSE and CH1641-scrapieJan P M Langeveld, Jorg G Jacobs, Jo H F Erkens, et al.
Nature Metabolism|July 23, 2020
An artificial intelligence decision support system for the management of type 1 diabetesNichole S Tyler, Clara M Mosquera-Lopez, Leah M Wilson, et al.
The Journal of Trauma and Acute Care Surgery|November 19, 2021
American Association for the Surgery of Trauma/American College of Surgeons-Committee on Trauma Clinical Protocol for inpatient venous thromboembolism prophylaxis after traumaBrian K Yorkgitis, Allison E Berndtson, Alisa Cross, et al.
Pageof 80

Showing results (681-690 of 791) with videos related to

Sort By:
Pageof 80
Annals of the Rheumatic Diseases|March 17, 2011
Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA studyM F Bakker, J W G Jacobs, P M J Welsing, et al.
Arthritis Research & Therapy|September 10, 2020
The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trialM S Jurgens, M Safy-Khan, M J H de Hair, et al.
Arthritis Care & Research|March 26, 2021
Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) ScoresMaxime M A Verhoeven, Antonius A A Westgeest, Andreas Schwarting, et al.
Arthritis Research & Therapy|October 17, 2018
Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biologyXavier M Teitsma, Wei Yang, Johannes W G Jacobs, et al.
Annals of the Rheumatic Diseases|June 1, 2010
Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA studyM F Bakker, J W G Jacobs, P M J Welsing, et al.
Arthritis and Rheumatism|October 29, 2005
Is radiation synovectomy for arthritis of the knee more effective than intraarticular treatment with glucocorticoids? Results of an eighteen-month, randomized, double-blind, placebo-controlled, crossover trialZalima N Jahangier, Johannes W G Jacobs, Floris P J G Lafeber, et al.
The Journal of Rheumatology|August 3, 2020
Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid ArthritisMaxime M A Verhoeven, Janneke Tekstra, Jacob M van Laar, et al.
Prion|December 20, 2014
Sheep prions with molecular properties intermediate between classical scrapie, BSE and CH1641-scrapieJan P M Langeveld, Jorg G Jacobs, Jo H F Erkens, et al.
Nature Metabolism|July 23, 2020
An artificial intelligence decision support system for the management of type 1 diabetesNichole S Tyler, Clara M Mosquera-Lopez, Leah M Wilson, et al.
The Journal of Trauma and Acute Care Surgery|November 19, 2021
American Association for the Surgery of Trauma/American College of Surgeons-Committee on Trauma Clinical Protocol for inpatient venous thromboembolism prophylaxis after traumaBrian K Yorkgitis, Allison E Berndtson, Alisa Cross, et al.
Pageof 80